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Abstract
Background Bisphosphonates have been shown to increase metacarpal cortical width. Bone health index is computed from hand
radiographs by measuring cortical thickness, width and length of the three middle metacarpals, and may potentially help predict
fracture risk in children.
Objective To compare bone health index with bone mineral density as measured from dual energy X-ray absorptiometry scans in
patients with and without bisphosphonate treatment.
Materials andmethods Two hundred ninety-three Caucasian patients (mean age: 11.5±3.7 years) were included.We documented
absolute values and z-scores for whole-body less head and lumbar spine bone mineral density then correlated these with the bone
health index, which were acquired on the same day, in different patient groups, depending on their ethnicity and diagnosis.
Results Bone health index showedmoderate to strong correlation with absolute values for whole-body (r=0.52) and lumbar spine
(r=0.70) bonemineral density in those not treated with bisphosphonates andmoderate correlation absolute values for whole-body
(r=0.54) and lumber spine (r=0.51) bone mineral density for those treated with bisphosphonates. There was weak correlation of
z-scores, ranging from r=0.11 to r=0.35 in both groups.
Conclusion The lack of a strong correlation between dual energy X-ray absorptiometry and bone health index suggests that they
may be assessing different parameters.
Keywords Bisphosphonates . Bone health index . Bonemineral density . Children . Dual energy x-ray absorptiometry
Introduction
Assessment of bone mineral density and bone quality is es-
sential to diagnose patients with diseases affecting the skele-
ton. In children, the reference standard for assessing bone
mineral density is dual energy x-ray absorptiometry. Dual en-
ergy x-ray absorptiometry is a valuable tool in patient
management, where bone mineral density is assessed at ap-
propriate intervals to monitor response to therapy in patients
with low bone mass [1]. Bisphosphonates are commonly used
in such patients (e.g., those with osteogenesis imperfecta) and
have been shown to increase cortical width [2]. However, dual
energy x-ray absorptiometry values are influenced by bone
size; therefore, bonemineral density is usually underestimated
in children with small bones and overestimated in children
with large bones because the depth of the bone is not
accounted for [3]. Additionally, dual energy x-ray absorptiom-
etry cannot predict fracture risk in children. Rather, it forms
part of a comprehensive skeletal health assessment to monitor
patients with low bone mineral density.
During the last three decades, quantitative bone imaging
techniques have been improved and tools for analysing im-
ages have been developed. One of these methods is
radiogrammetry, where the middle phalangeal width and cor-
tical thickness are measured and results are presented as the
cortical index [4]. Computer software developed specifically
for children automatically calculates bone age and bone mass
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[5]. The software measures the cortical thickness, width and
length of the three middle metacarpals and results are
expressed as the bone health index. The software also pro-
vides a standard deviation score, which enables comparison
with healthy Caucasian children. A small number of studies
suggest a potential role for the use of bone health index in
assessing bone health in children [6–8]. However, there are
limitations to these studies, including small participant num-
bers [6, 7] and an extended interval of up to 8 months between
dual energy x-ray absorptiometry and radiographs [8].
Patients on bisphosphonate therapy were not included in pre-
vious studies, yet this group may benefit the most, given that
bisphosphonates increase cortical thickness, the very parame-
ter on which the bone health index is based.
The aim of this study is to compare bone health index with
bone mineral density dual energy x-ray absorptiometry read-
ings acquired on the same day for different clinical reasons in
a large cohort of children, including children on bisphospho-
nate treatment.
Materials and methods
All procedures performed in this study were in accordance
with the ethical standards of our institution. For this study,
formal patient consent and research ethics committee approval
were not required.
Patient selection
We retrospectively identified dual energy x-ray absorptiome-
try scans and left-hand radiographs of patients who attended
Sheffield Children’s NHS Foundation Trust Hospital, United
Kingdom, between February 2010 and January 2017. The
following inclusion criteria were applied: (1) patients 5–
18 years old and (2) dual energy x-ray absorptiometry scans
and hand radiographs obtained on the same day.
Hand radiography and dual energy x-ray
absorptiometry
BoneXpert software (PACS Server version; Visiana, Holte,
Denmark) was used to analyse the hand radiographs [5]. All
radiographs were in DICOM format. The software calculated
the bone health index based on cortical thickness, width and
the length of the three middle metacarpals (Fig. 1).
For bone health index calculations, Caucasian was the de-
fault ethnicity at the time of analysis. The data was analysed
according to whether patients were or were not on bisphos-
phonate treatment. Cases were excluded from the study if the
BoneXpert software was unable to read the radiograph.
Area bone mineral density of total body less head and lum-
ber spine L1-L4 were extracted from each patient’s dual
energy x-ray absorptiometry scan. These values were adjusted
for age and gender based on normative data provided by the
manufacturer. Patient age, gender and the indication for dual
energy x-ray absorptiometry were extracted.
Statistical analysis
Statistical analysis was performed using SPSS version 25 for
PC (IBM, Armonk, NY). The z-scores of bone mineral den-
sity of the total body less head and spine were adjusted for
bone age to evaluate the impact of this adjustment on correla-
tion with the bone health index standard deviation score. Each
z-score adjusted for bone age for those patients treated with
bisphosphonates is based on the computed z-score values (i.e.
the internally standardised residuals from the regression anal-
ysis that includes bone age) from the untreated patients. The
correlation between bone health index and bone mineral den-
sity of the total body less head and the spine was assessed
separately using Pearson’s correlation. Additionally, correla-
tion between bone health index standard deviation score and
z-score of bone mineral density of the total body less head and
the spine was assessed separately. The correlation between the
adjusted z-scores and bone health index standard deviation
score were then determined. The strength of the correlations
was interpreted according to Evans [9], in which the correla-
tion is deemed to be very weak when the r value is less than
0.19, weak between 0.20 and 0.39, moderate between 0.40
and 0.59, strong between 0.60 and 0.79, and very strong be-
tween 0.80 and 1.0. Finally, we generated Bland-Altman plots
to graphically illustrate the strength of agreement between the
two modalities for the non-bisphosphonate and bisphospho-
nate groups.
Results
Patient characteristics
Initially, 577 dual energy x-ray absorptiometry/radiograph
pairs were identified. Diagnoses included osteogenesis
imperfecta (51%), primary osteoporosis (9.5%) and recurrent
fracture (5.8%). All diagnoses/indications and patient charac-
teristics are presented in Tables 1 and 2, respectively.
BoneXpert could not interpret 31 (5.6%) radiographs for a
number of reasons, including abnormal bone shape, cortical
inconsistencies, inconsistencies in length and the image being
too sharp. A total of 189 dual energy x-ray absorptiometry/
radiograph pairs were excluded as these pairs were acquired
for follow-up, which would bias statistical analyses. No dual
energy x-ray absorptiometry/radiograph pair was identified
for Africans in comparison to a total of 32 dual energy x-ray
absorptiometry/radiograph pairs for Asians. However, the
Asian patients were excluded from the analysis due to the
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small number of dual energy x-ray absorptiometry/radiograph
pairs identified. Therefore, the final analysis included dual
energy x-ray absorptiometry and hand radiographs of 293
patients, 172 (59%) of whom had received bisphosphonate
treatment.
Dual energy X-ray absorptiometry and bone health
index
As an overall analysis, bone health index correlated moderate-
ly with the absolute values of bone mineral density, the total
Fig. 1 Left-hand radiographs in
two 10-year-old Caucasian boys
show relatively similar bone
health index: (a) bisphosphonate
naïve and (b) on bisphosphonate
treatment. BA (GP) bone age
using Greulich and Pyle’s atlas,
BHI bone health index, SDS
standard deviation score, TW3
Tanner-Whitehouse 3
Table 1 Diagnosis or indication
for investigation No bisphosphonate treatment Current/past bisphosphonate treatment
Acute back pain 4
Bone marrow transplant 7
Calcinosis cutis 6
Cerebral palsy 9
Crohn disease 5 3
Cystic fibrosis 9 4
Fanconi anemia 3
Growth delay 13
Hypocalcemia 6
Hypophosphatasia 4
Juvenile arthritis 10 8
Malabsorption 4
Osteogenesis imperfecta 12 138
Post colectomy 3
Primary osteoporosis 15 13
Recurrent fracture 11 6
Total 121 172
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body and the spine (P<0.01) (Table 3). The data were then
divided into two groups depending on whether patients had
received bisphosphonate treatment. As seen in Table 3, corre-
lation was stronger in the non-bisphosphonate group as
depicted by bone mineral density of the total body (r=0.70)
and the spine (r=0.52, P<0,01).
The bone health index standard deviation score showed
weak correlation with z-score of the total body less head and
the spine (adjusted only for age and gender) in both groups
(Table 3). The z-score of bone mineral density of the total
body less head and the spine were then adjusted for bone
age. The relationship of bone mineral density of the spine
adjusted for age and gender alone and adjusted for age, gender
and bone age showed similar slopes in both groups with
Pearson correlation of 0.74 (r2=0.54) (Fig. 2). Additionally,
the relationship of bone mineral density of the total body less
head adjusted for age and gender alone and adjusted for age,
gender and bone age showed similar slopes in both groups,
with Pearson correlation of 0.459 (r2=0.21%) (Fig. 2). The
bone health index standard deviation score showed weak cor-
relation with the z-score of bone mineral density of the total
body less head and the spine (adjusted for age, gender and
bone age) (Table 3). Bland-Altman plots showed limited
agreement between z-score of bone mineral density of the
total body less head and the spine (adjusted for age, gender
and bone age) and bone health index standard deviation scores
(Fig. 3).
Discussion
This study compares bone mineral density measured by dual
energy x-ray absorptiometry with bone mass calculated by
BoneXpert in a cohort of Caucasian children. BoneXpert
was able to provide a reading in the majority of cases. For
bisphosphonate naïve children, there was strong correlation
Table 3 Correlation coefficients between bone health index and dual energy x-ray absorptiometry, and bone health index standard deviation scores and
z-score reads in bisphosphonate naive and treated patients
Overall P-value Bisphosphonate
group
P-value Non-bisphosphonate
group
P-value
Bone health index Bone mineral density-spine 0.59 <0.01 0.52 <0.01 0.70 <0.01
Bone mineral density-total body 0.53 <0.01 0.54 <0.01 0.52 <0.01
Bone health
index standard
deviation scores
Z-score of bone mineral
density-spine
0.17 <0.01 0.047 0.26 0.35 <0.01
Z-score of bone mineral
density-total body
0.24 <0.01 0.19 0.20 0.31 <0.01
Bone health
index standard
deviation scores
Z-score of bone mineral
density-spine
(adjusted for bone age)
0.22 0.03 0.12 0.12 0.35 <0.01
Z-score of bone mineral
density-total body
(adjusted for bone age)
0.26 <0.01 0.26 <0.01 0.25 <0.01
Table 2 Dual energy x-ray absorptiometry and bone health index measurements
Bisphosphonate group mean
(standard deviation)
Non-bisphosphonate group mean
(standard deviation)
Number 172 121
Age (years) 12 (3.5) 11.0 (4.0)
Bone age* (years) 12 (3.7) 9.9 (4.3)
Bone mineral density-spine 0.82 (0.18) 0.83 (0.23)
Z-score of bone mineral density-spine −0.77 (1.5) −0.26 (1.6)
Adjusted z-score of bone mineral density-spine 0.0 (1.0) 0.5 (1.3)
Bone mineral density-total body 0.86 (0.16) 0.77 (0.19)
Z-score of bone mineral density-total body −0.62 (1.4) −0.43 (1.4)
Adjusted Z-score of bone mineral density-total body 0.0 (1.0) −0.42 (1.1)
Bone health index 4.4 (0.61) 4.2 (0.68)
Bone health index standard deviation score −1.2 (1.2) −1.3 (1.5)
*Greulich and Pyle method
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between bone health index and dual energy x-ray absorptiom-
etry absolute values. Previous studies have shown similar cor-
relation ranging from r=0.58 to r=0.85, although ethnicity of
patients was not mentioned [6–8].
BoneXpert also provides a bone health index standard de-
viation score based on data collected from healthy Caucasian
children. The bone health index standard deviation score pro-
vides a measure of the extent to which a patient’s bone mass is
deviated from that of healthy Caucasian children of the same
bone age and gender. We found a weak correlation between
the bone health index standard deviation score and z-scores of
dual energy x-ray absorptiometry, even after adjusting the z-
scores for bone age. The reasons for this are uncertain but
might include differences in other parameters of reference
and study populations. Bland-Altman plots showed systemat-
ic bias in which differences are higher than means when
means are lower, and the differences do not reach zero until
the average value reaches or exceeds two standard deviations.
However, this is more likely to be due to the fact that the data
adjusted for bone age are based on the computed z-score
values from patients who had no bisphosphonate treatment.
The bone health index of patients who had not been on
bisphosphonate treatment showed a strong correlation, which
might suggest that bone health index is a useful tool tomonitor
children’s bone health in this group of patients. In the bisphos-
phonate group, bone health index showed moderate correla-
tion with absolute dual energy x-ray absorptiometry measures.
Approximately 79% of the bisphosphonate group were
Fig. 2 The relationship of z-score
adjusted for age and gender alone,
and z-score adjusted for age,
gender and bone age show similar
slopes: (a) bone mineral density
of the spine and (b) bone mineral
density of the whole body
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patients with osteogenesis imperfecta. The metacarpals of that
group of patients have smaller bone thickness (external size)
and thinner cortices than normal [10]. During treatment with
bisphosphonates, cortical thickness increases [11]. This is
likely to offer BoneXpert an advantage in this particular group
of patients, as the bone health index measured by BoneXpert
is dependent on cortical structure, while dual energy x-ray
absorptiometry depends on both cortical and trabecular struc-
tures. The weaker correlation between bone health index and
dual energy x-ray absorptiometry in this group of patients may
be because bone health index more closely reflects the true
state of the children’s bones than dual energy x-ray absorpti-
ometry and merits studies to assess its role in predicting frac-
ture risk in children.
Fig. 3 Bland-Altman plots for the
difference in bonemineral density
adjusted for bone age, and bone
health index z-score, versus the
mean of the two estimates. aBone
mineral density of the spine. b
Bone mineral density of the
whole body. The plots show
limited agreement between z-
scores of bone mineral density of
the total body less head and of the
spine
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There are some limitations to this study. Firstly, dual energy
x-ray absorptiometry z-scores were adjusted for gender, age
and ethnicity but not for height and weight. Adjusting for
height and weight is expected to explain some of the variance
because dual energy x-ray absorptiometry reads may be af-
fected by those parameters. Additionally, dual energy x-ray
absorptiometry z-scores adjusted for bone age are based on
the computed z-score values from patients who had no bis-
phosphonate treatment. Ideally, these scores should be based
on the z-scores of a healthy population, which were not avail-
able to the authors.
Conclusion
The lack of a strong correlation between dual energy x-ray
absorptiometry and bone health index suggests that they
may be assessing different parameters. The role of bone health
index in assessing bone health in children warrants further
study before it can be used as an adjunct to or replacement
for dual energy x-ray absorptiometry. Future studies need to
investigate the clinical use of the bone health index values for
predicting fracture risk.
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